RHODA NDAMUKONG: Open Payments
NPI 1477017085 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 64 payments from 14 companies in 2025. Trend: 2023 $1,758 · 2024 $2,189 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $409 |
| Boston Scientific Corporation | 12 | $296 |
| Abbott Laboratories | 4 | $232 |
| Medtronic, Inc. | 5 | $164 |
| MERZ NORTH AMERICA, INC. | 1 | $139 |
| SCILEX PHARMACEUTICALS INC. | 5 | $114 |
| PFIZER INC. | 4 | $105 |
| Collegium Pharmaceutical, Inc. | 4 | $69 |
| Valinor Pharma, LLC | 3 | $52 |
| TMS NeuroHealth Centers Inc. | 1 | $24 |
Products named: WaveWriter Alpha Prime 16, PROCLAIM, QULIPTA, UBRELVY, INTELLIS ADAPTIVESTIM, ZTLido, NURTEC ODT, XTAMPZA.
Industry payments across MD — which companies pay providers there.
